{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:21:15Z","timestamp":1789161675085,"version":"build-2803163510"},"reference-count":33,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Behavioral Health Systems Baltimore","award":["16-114-5704-000"],"award-info":[{"award-number":["16-114-5704-000"]}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["T32-DA007293 (PI: Renee Johnson)"],"award-info":[{"award-number":["T32-DA007293 (PI: Renee Johnson)"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Background<\/jats:italic>\n                    : Treatment for opioid use disorder involving opioid-based pharmacotherapies is considered most effective when accompanied by psychosocial interventions. Peer-led support groups are widely available and have been described by many as fundamental to the recovery process. However, some individuals using medications face stigma in these settings, which can be contradictory and counterproductive to their recovery.\n                    <jats:italic toggle=\"yes\">Methods<\/jats:italic>\n                    : This paper describes the development of the \u201cAbility, Inspiration and Motivation\u201d or \u201cAIM\u201d group, an alternative peer support group that aims to remove medication stigma from peer recovery. Qualitative interviews with staff, peers, and clients of a community-based buprenorphine treatment program were used to establish the core components of the curriculum to support client needs.\n                    <jats:italic toggle=\"yes\">Results<\/jats:italic>\n                    : Staff, peers, and clients of the buprenorphine program indicated a need and desire to establish a peer recovery group that recognizes persons on medication as being in recovery and destigmatizes use of medication to treat opioid addiction. A respectful environment, holistic perspective on health, spirituality, sharing, and celebration were all established as necessary pillars of the AIM group curriculum.\n                    <jats:italic toggle=\"yes\">Conclusions<\/jats:italic>\n                    : The community-based effort to establish and develop the AIM group demonstrates that combining the strengths of a peer support with evidence-based medication treatment is both possible and desirable. Shifting the culture of peer recovery groups to support the use of medications may have implications for improving treatment retention and should be considered as a potential strategy to reduce the burden of the opioid epidemic.\n                  <\/jats:p>","DOI":"10.1080\/08897077.2018.1439798","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T13:05:21Z","timestamp":1518440721000},"page":"404-409","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":57,"title":["Overcoming Medication Stigma in Peer Recovery: A New Paradigm"],"prefix":"10.1177","volume":"39","author":[{"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Behavioral Health Leadership Institute, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianna","family":"Negron","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Agus","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Behavioral Health Leadership Institute, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Fingerhood","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301049"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1402780"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694598"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000193"},{"key":"e_1_3_4_10_2","unstructured":"American Society of Addiction Medicine. National practice guideline for the use of medications in the treatment of addiction involving opioid use. 2015. https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-supplement.pdf. Accessed November 28 2016."},{"key":"e_1_3_4_11_2","unstructured":"Han B Hedden S Lipari R Copello E Kroutil L. Receipt of Services for Behavioral Health Problems: Results From the 2014 National Survey on Drug Use and Health. xx xx: Substance Abuse and Mental Health Services Administration; 2015. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DR-FRR3-2014\/NSDUH-DR-FRR3-2014\/NSDUH-DR-FRR3-2014.pdf. Accessed December 1 2016."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826088509047242"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1187241"},{"key":"e_1_3_4_14_2","volume-title":"Social & Legal Perspectives on Underuse of Medication-Assisted Treatment for Opioid Dependence","author":"Andraka-Christou B","year":"2016","unstructured":"Andraka-Christou B. Social & Legal Perspectives on Underuse of Medication-Assisted Treatment for Opioid Dependence. Indiana University; 2016."},{"key":"e_1_3_4_15_2","unstructured":"NA World Services. NA groups & medication. Item No 2205. Chatsworth CA. https:\/\/www.na.org\/admin\/include\/spaw2\/uploads\/pdf\/servicemat\/Dec2011_NA_Groups_and_Medication.pdf. Published 2007. Accessed November 5 2016."},{"key":"e_1_3_4_16_2","unstructured":"White WL. Narcotics Anonymous and the Pharmacotherapeutic Treatment of Opioid Addiction in the United States. Chicago IL: Philadelphia Department of Behavioral Health and Intellectual Disability Services and Great Lakes Addiction Technology Transfer Center; 2011. http:\/\/atforum.com\/documents\/2011NAandMedication-assistedTreatment.pdf. Accessed Nov 28 2016."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.08.002"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.05.005"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700804"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5475"},{"key":"e_1_3_4_21_2","unstructured":"Maryland Department of Health and Mental Hygiene. Drug- and Alcohol-Related Intoxication Deaths in Maryland 2014. https:\/\/bha.health.maryland.gov\/OVERDOSE_PREVENTION\/Documents\/2015%20Annual%20Report_final.pdf. Published June 2016. Access November 28 2016."},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000004"},{"key":"e_1_3_4_23_2","unstructured":"Behavioral Health Leadership Institute. Project connections buprenorphine program: program and Client summary 2010\u20132016. http:\/\/mail.bhli.org\/pdf\/BHLIBupeProgramReportSept2016.pdf. Published September 2016. Accessed January 28 2017."},{"key":"e_1_3_4_24_2","unstructured":"Maintenance and recovery services. Mars methadone web site. http:\/\/marsmethadone.com\/about-us. Updated 2016. Accessed November 6 2016."},{"key":"e_1_3_4_25_2","unstructured":"SMART recovery\u2014self-management for addiction recovery. SMART recovery web site. http:\/\/www.smartrecovery.org\/. Updated 2016. Accessed November 6 2016."},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897070109511466"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/1556035X.2012.705699"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/1556035X.2013.836872"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301191"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.7.861"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-45375-5_23"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3674"},{"key":"e_1_3_4_34_2","unstructured":"US Department of Health and Human Services (HHS) Office of the Surgeon General. Facing addiction in America: the surgeon general's report on alcohol drugs and health. https:\/\/addiction.surgeongeneral.gov\/surgeon-generals-report.pdf. Published 2016. Accessed November 19 2016."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2018.1439798","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2018.1439798","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2018.1439798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:49:37Z","timestamp":1777625377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2018.1439798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1080\/08897077.2018.1439798"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2018.1439798","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}